Tallinn, Estonia - AMAZING town

At long last and with much tribulation, I'm finished with this album. I truly loved this city. I could go back and spend at least a week there exploring every nook and cranny of the Old City. The culture and the language really both intrigued me as well. The history of the nation and its people is fascinating. I can't really stop talking, thinking, and dreaming about this town, actually. Here's a small glimpse into Tallinn, Estonia. Enjoy!!

Pfizer settlement!! YAY!

About time for these settlements!! Pfizer, IMHO, is soooo corrupt.

Said Pfizer's Sr. VP & general counsel, Amy W. Schulman, "These agreements bring final closure to significant legal matters & help to enhance our focus on what we do best - discovering, developing & delivering innovative medicines to treat patients dealing with some of the world's most debilitating diseases..."

All of Pfizer management is so keen on dishing out loads of bull to the public. It's amazing to me that with so many FDA lawsuits over the years for illegal marketing (Viagra, Bextra, etc.) that they haven't lost more public love. It's also amazing that the FDA's not slapping them for more money. Keep an eye out for Pfizer TV and radio ads. When I was working for them (3 yrs), the company was always under fire for illegal marketing campaigns. It never makes me feel good about my company when everyone's against them - legitimately!!

Such bullsh*t!

LOVE THIS: "Combating health care fraud is one of [the Obama] administration's top priorities," Assoc. Attorney General Thomas Perelli said in announcing the settlement. He said it illustrates ways the department "can help the American public at a time when budgets are tight and health care costs are rising."

It would be fantastic if the feds can make drug prices fixed along with general health care reform. Right now the sky's not the limit for new drug research. There is no reason in this world why less money can be spent on drug R&D and still find new and better cures. If a limit is set by the feds on R&D, then pharma companies will have to find new and less expensive ways for creating drugs.

As long as necessity is the mother of invention, spending limits on R&D are the surrogate of lower drug prices.